Gene · 5352
Papers1,610
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,610
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics analysis of parthanatos related molecular subgroup and prognostic model development in stomach adenocarcinoma. | PLoS One | 2025 | 41004487 | PubTator, text mining | PubMed |
| Role of glycolysis related genes in the pathogenesis of hemorrhoids and immune cell infiltration analysis. | Sci Rep | 2025 | 40998906 | PubTator, text mining | PubMed |
| An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. | Nat Commun | 2025 | 40993118 | PubTator, text mining | PubMed |
| Stenotrophomonas muris-first discovered as a potential human pathogen with strong virulence and antibiotic resistance, associated with bloodstream infections. | Microbiol Spectr | 2025 | 40985695 | PubTator, text mining | PubMed |
| Bridging the gap of late-gestation nephrogenesis using a non-human primate model. | bioRxiv | 2025 | 40894529 | PubTator, text mining | PubMed |
| Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches. | Cancer Med | 2025 | 40884151 | PubTator, text mining | PubMed |
| Cell Surface Proteomics Reveals Hypoxia-Regulated Pathways in Cervical and Bladder Cancer. | Proteomes | 2025 | 40843709 | PubTator, text mining | PubMed |
| Multiple golgins are required to support extracellular matrix secretion, modification, and assembly. | J Cell Biol | 2025 | 40824304 | PubTator, text mining | PubMed |
| Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy. | Cell Death Discov | 2025 | 40813760 | PubTator, text mining | PubMed |
| Hypoxic stimulation of DCLK1 transcription and alternative-promoter switching fuels tumor malignancy in clear cell renal cell carcinoma. | Cell Death Dis | 2025 | 40775208 | PubTator, text mining | PubMed |
| Enzymatic craftsmanship in collagen glycosylation. | Nat Commun | 2025 | 40770197 | PubTator, text mining | PubMed |
| AKT inhibitors in gynecologic oncology: past, present and future. | Front Oncol | 2025 | 40746599 | PubTator, text mining | PubMed |
| CKAP4 and PLOD2 as novel prognostic biomarkers in hepatocellular carcinoma: a proteomics-driven risk stratification model. | Front Cell Dev Biol | 2025 | 40673276 | PubTator, text mining | PubMed |
| Antigen-presenting CAFs orchestrate immunosuppressive niches via CXCL13-mediated immune cell infiltration dysregulation and prognostic stratification in triple-negative breast cancer. | Int Immunopharmacol | 2025 | 40633212 | PubTator, text mining | PubMed |
| Development and interpretation of a pathomics-driven ensemble predictive model for prognosis of intrahepatic cholangiocarcinoma. | Eur J Surg Oncol | 2025 | 40627917 | PubTator, text mining | PubMed |
| Iron metabolism and preeclampsia: new insights from bioinformatics analysis. | J Matern Fetal Neonatal Med | 2025 | 40592741 | PubTator, text mining | PubMed |
| Integrative Spatial Proteomics and Single-Cell RNA Sequencing Unveil Molecular Complexity in Rheumatoid Arthritis for Novel Therapeutic Targeting. | Proteomes | 2025 | 40559990 | PubTator, text mining | PubMed |
| Radiogenomic correlation of hypoxia-related biomarkers in clear cell renal cell carcinoma. | J Cancer Res Clin Oncol | 2025 | 40500522 | PubTator, text mining | PubMed |
| Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer. | BMC Gastroenterol | 2025 | 40229676 | PubTator, text mining | PubMed |
| Metabolism-related ALDH1B1 acts as potential predictor and therapeutic target for primary gastrointestinal diffuse large B-cell lymphoma. | Apoptosis | 2025 | 40216643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5352/papers?page=3